TWD 9.83
(2.72%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 55.81 Million TWD | 96.59% |
2022 | 28.39 Million TWD | -11.94% |
2021 | 32.23 Million TWD | -65.31% |
2020 | 92.92 Million TWD | 1690.5% |
2019 | 5.19 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 56.22 Million TWD | 0.0% |
2024 Q1 | 56.22 Million TWD | 0.75% |
2023 Q1 | 23.08 Million TWD | -18.68% |
2023 Q2 | 25.84 Million TWD | 11.95% |
2023 FY | 55.81 Million TWD | 96.59% |
2023 Q4 | 55.81 Million TWD | 0.0% |
2023 Q3 | 55.81 Million TWD | 115.94% |
2022 Q3 | 25.63 Million TWD | 0.0% |
2022 Q4 | 28.39 Million TWD | 10.76% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 90.434% |
Level Biotechnology Inc. | 273.2 Million TWD | 79.571% |
Sagittarius Life Science Corp | 137.82 Million TWD | 59.504% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | 71.736% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 95.797% |
GlycoNex Incorporation | 276.39 Million TWD | 79.807% |
VBI | 21.25 Million TWD | -162.637% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 82.209% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 89.155% |
Visgeneer Inc. | 185.6 Million TWD | 69.929% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 95.782% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 92.386% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 53.435% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.515% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -743.351% |
Enimmune corporation | 173.46 Million TWD | 67.824% |
TaiRx, Inc. | 60.62 Million TWD | 7.937% |
CHO Pharma, Inc. | 110.83 Million TWD | 49.642% |
EirGenix Inc. | 1.14 Billion TWD | 95.126% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 50.159% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 89.108% |
Lin BioScience, Inc. | 167.73 Million TWD | 66.724% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 40.443% |
Feng Chi Biotech Corp. | 63.03 Million TWD | 11.456% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | 55.253% |
Lukas Biomedical Inc. | 161.05 Million TWD | 65.346% |
RBC Bioscience Corporation | 513.08 Million TWD | 89.122% |
BiOptic Inc. | 170.56 Million TWD | 67.277% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -32.39% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -140.004% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -108.156% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 94.273% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -698.013% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -162.946% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 84.847% |
Neith Corporation | 17.43 Million TWD | -220.157% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -600.113% |
NaviFUS Corp. | 53.4 Million TWD | -4.517% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 88.408% |
Sinew Pharma Inc. | 39.71 Million TWD | -40.537% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 3.835% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 84.687% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 75.488% |
AP Biosciences Inc | 106.65 Million TWD | 47.667% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.419% |
3D Global Biotech Inc. | 30.68 Million TWD | -81.914% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | 71.523% |
Intech Biopharm Corporation | 1.54 Billion TWD | 96.383% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 93.558% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -501.693% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 76.042% |
TCI GENE Inc. | 155.54 Million TWD | 64.118% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -118.806% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -20.873% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 83.008% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 13.984% |
PharmaEngine, Inc. | 91 Million TWD | 38.671% |
Savior Lifetec Corporation | 457.95 Million TWD | 87.813% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 49.691% |
OBI Pharma, Inc. | 650.44 Million TWD | 91.419% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 85.719% |
Acepodia, Inc. | 384.47 Million TWD | 85.483% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 34.762% |